SEC Form 4 · accession 0001144204-15-016825

Minerva Neurosciences, Inc. · NERV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

10% Owner

10% Owner

Period of report

Mar 13, 2015

Accepted (ET)

Mar 17, 2015 · 6:43 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001598646

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2,F3	Mar 13, 2015	P	607,903	$4.81	A	4,500,159	I	By Johnson & Johnson Innovation - JJDC, Inc.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrants (right to buy)^F1,F3	$5.772	Mar 13, 2015	P	607,903	A	Mar 18, 2015	Mar 18, 2017	Common Stock	607,903	607,903	I

F1The transaction is subject to customary closing conditions and is expected to close on or about 03/18/2015.
F2Consists of 3,892,256 shares of Common Stock and 607,903 shares of Common Stock underlying immediately exercisable warrants.
F3The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person (formerly known as Johnson & Johnson Development Corporation).